Highlights in the media today: Indonesia manages to sequence its SARS-CoV-2 genome, violations continue to occur in the second phase of the large-scale social restrictions (PSBB), PLN to provide six months of free electricity for small businesses

The Eijkman Institute for Molecular Biology has successfully completed the whole genome sequencing of SARS-CoV-2.  The genome data, which was obtained from three isolates from Indonesian patients, is needed to understand the characteristics of the novel coronavirus in Indonesia. The institute currently aims to sequence the genomes of 100 SARS-CoV-2 specimens in Indonesia.

Meanwhile, according to a study published on medRxiv.org by Li Lanjuan and a team of researchers from Zhejiang University in Hangzhou, China, the virus has mutated into at least 30 different strains.

As of May 5 16:38 (GMT+7), Indonesia had confirmed 12,071 COVID-19 cases with 2,197 recoveries and 872 deaths. Around 116,861 specimens had been tested in 46 laboratories as of May 4.

Compliance remains an issue in the second phase of large-scale social restrictions (PSBB) in the Greater Jakarta area. Tangerang Public Order Agency (Satpol PP) Head Agus Hendra said that there have been more gatherings of people in the second phase of the PSBB and linked it to the iftar gathering tradition.

Several restaurants in Tangerang City are also still providing dine-in service. The agency was said to have closed 40 businesses in the city so far. Meanwhile, Jakarta Manpower Office Head Andri Yansyah said that following inspections conducted from April 14 to May 4, 841 companies have been found to have violated PSBB rules.

State electricity firm PLN has also announced its intention to supply small businesses and industries on 450-volt ampere (VA) contracts with six months of free electricity. PLN President Director Zulkifli Zaini said that the company has started gathering data of around 500,000 prepaid customers from small businesses and industries eligible for the aid.

 

Source:

Share this:

Leave a Reply

Your email address will not be published. Required fields are marked *